The researchers said their findings do not support the use of ivermectin for patients with COVID-19.
KUALA LUMPUR: (Reuters) Malaysian researchers found that treatment with the anti-parasite drug Ivermectin did not prevent patients with Covid-19 from becoming severely ill in a randomised clinical trial published in the Jama Internal Medicine journal on Friday.
The researchers said their findings do not support the use of Ivermectin for patients with Covid-19.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
